Authors:
MITRA R
CANNON L
ABELA G
WATSON R
DWAMENA F
MCLANE A
KUPERSMITH J
Citation: R. Mitra et al., BLACK PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION ARE MORE LIKELY THAN WHITES TO HAVE NO SIGNIFICANT OCCLUSION ON CARDIAC-CATHETERIZATION, Journal of investigative medicine, 44(7), 1996, pp. 348-348
Authors:
WATSON R
MITRA R
DWAMENA F
KROLL J
VASILENKO P
MCINTOSH B
GARDINER J
STOMMEL M
KUPERSMITH J
Citation: R. Watson et al., RACE INFLUENCES THE RATE OF CARDIAC-CATHETERIZATION, BUT DOES NOT INFLUENCE THE RATES OF PTCA AND CABG FOLLOWING ACUTE MYOCARDIAL-INFARCTION, Journal of investigative medicine, 44(7), 1996, pp. 348-348
Authors:
DWAMENA F
MITRA R
WATSON R
GARDINER J
ABELA G
VASILENKO P
KUPERSMITH J
Citation: F. Dwamena et al., DO COMMUNITY PHYSICIANS PRESCRIBE ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS TO PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Journal of investigative medicine, 44(7), 1996, pp. 388-388
Authors:
WATSON R
MITRA R
DWAMENA F
KROLL J
VASILENKO P
SMITH S
STOMMEL M
KUPERSMITH J
Citation: R. Watson et al., GENDER DOES NOT INFLUENCE THE RATE OF CARDIAC-CATHETERIZATION, BUT DOES INFLUENCE THE RATES OF PTCA AND CABG FOLLOWING ACUTE MYOCARDIAL-INFARCTION, Journal of investigative medicine, 44(7), 1996, pp. 388-388
Authors:
VASILENKO P
DAVIS S
MULPURI V
GHORESHI E
WATSON R
KUPERSMITH J
Citation: P. Vasilenko et al., RACIAL AND GENDER DIFFERENCES IN THE LOCATION OF CARDIAC DEATH - A COMMUNITY PERSPECTIVE, Journal of investigative medicine, 44(7), 1996, pp. 389-389
Authors:
MITRE R
ABELA G
WATSON R
DWAMENA F
VASILENKO P
FAZALURREHMAN S
KUPERSMITH J
Citation: R. Mitre et al., LIPID-LOWERING DRUGS ARE UNDERPRESCRIBED IN ACUTE MYOCARDIAL-INFARCTION PATIENT POPULATION, Journal of investigative medicine, 44(7), 1996, pp. 390-390
Authors:
MALDONADO C
LI ZY
WEAD WB
SZABO T
KUPERSMITH J
Citation: C. Maldonado et al., MECHANISMS OF TRIGGERED ACTIVITY INDUCTION AT THE BORDER ZONE OF NORMAL AND ABNORMAL CARDIAC TISSUE, Journal of electrocardiology, 29(4), 1996, pp. 309-318
Authors:
VASILENKO P
DAVIS S
MULPURI V
GHORESHI E
WATSON R
KUPERSMITH J
Citation: P. Vasilenko et al., RACIAL AND GENDER DIFFERENCES IN THE LOCATION OF CARDIAC DEATH - A COMMUNITY PERSPECTIVE, Circulation, 94(8), 1996, pp. 282-282
Authors:
SCHWARTZ KA
LI ZY
SCHWARTZ DE
COOPER TG
BRASELTON WE
KUPERSMITH J
Citation: Ka. Schwartz et al., THE RELATIONSHIP BETWEEN IRON-INDUCED DECREASES IN MR-T2 RELAXATION-TIMES END DEFECTS IN CARDIAC CONDUCTION IN THE IRON-LOADED GUINEA-PIG, Blood, 88(10), 1996, pp. 2116-2116
Citation: Jd. Talley et al., ECONOMIC AND ANGIOGRAPHIC FACTORS IN DETERMINING OPTIMAL CATHETER SIZE IN PERFORMING OUTPATIENT LEFT-SIDED HEART AND CORONARY ANGIOGRAPHY, The American journal of cardiology, 77(5), 1996, pp. 374-378
Authors:
KUPERSMITH J
HOLMESROVNER M
HOGAN A
ROVNER D
GARDINER J
Citation: J. Kupersmith et al., COST-EFFECTIVENESS ANALYSIS IN HEART-DISEASE .3. ISCHEMIA, CONGESTIVE-HEART-FAILURE, AND ARRHYTHMIAS, Progress in cardiovascular diseases, 37(5), 1995, pp. 307-346
Authors:
KUPERSMITH J
HOLMESROVNER M
HOGAN A
ROVNER D
GARDINER J
Citation: J. Kupersmith et al., COST-EFFECTIVENESS ANALYSIS IN HEART-DISEASE .2. PREVENTIVE THERAPIES, Progress in cardiovascular diseases, 37(4), 1995, pp. 243-271
Authors:
KUPERSMITH J
HOGAN A
GUERRERO P
GARDINER J
MELLITS ED
BAUMGARDNER R
ROVNER D
HOLMESROVNER M
MCLANE A
LEVINE J
SAKSENA S
GRIFFITH L
Citation: J. Kupersmith et al., EVALUATING AND IMPROVING THE COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, The American heart journal, 130(3), 1995, pp. 507-515
Authors:
JOSEPH G
JOSEPH A
TALLEY JD
YUSSMAN Z
KUPERSMITH J
VOGEL R
Citation: G. Joseph et al., A COMPARISON OF HEMOSTATIC PARAMETERS IN HYPOTHERMIC VERSUS NORMOTHERMIC CARDIOPULMONARY BYPASS, Journal of interventional cardiology, 7(1), 1994, pp. 7-16
Authors:
GUERRERO P
HOGAN A
GARDINER J
MELLITS ED
BAUMGARDNER RA
ROVNER D
HOLMESROVNER M
MCLANE A
LEVINE J
SAKSENA S
GRIFFITH L
KUPERSMITH J
Citation: P. Guerrero et al., IMPROVING COST-EFFECTIVENESS OF THE TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, Journal of the American College of Cardiology, 1994, pp. 10000206-10000206
Authors:
JOSEPH A
TALLEY JD
SHIH A
CRUM T
VOGEL R
KUPERSMITH J
Citation: A. Joseph et al., CLINICAL AND ANGIOGRAPHIC VARIABLES AFFECTING PROGRESSION OF CORONARY-ARTERY DISEASE DETERMINED BY QUANTITATIVE ANGIOGRAPHY, Journal of the American College of Cardiology, 1994, pp. 10000265-10000265
Authors:
MOYE LA
PFEFFER MA
WUN CC
DAVIS BR
GELTMAN E
HAYES D
FARNHAM DJ
RANDALL OS
DINH H
ARNOLD JMO
KUPERSMITH J
HAGER D
GLASSER SP
BIDDLE T
HAWKINS CM
BRAUNWALD E
Citation: La. Moye et al., UNIFORMITY OF CAPTOPRIL BENEFIT IN THE SAVE STUDY - SUBGROUP ANALYSIS, European heart journal, 15, 1994, pp. 2-8
Authors:
KUPERSMITH J
HOLMESROVNER M
HOGAN A
ROVNER D
GARDINER J
Citation: J. Kupersmith et al., COST-EFFECTIVENESS ANALYSIS IN HEART-DISEASE .1. GENERAL-PRINCIPLES, Progress in cardiovascular diseases, 37(3), 1994, pp. 161-184
Authors:
GARDINER J
HOGAN A
KUPERSMITH J
HOLMESROVNER M
ROVNER D
GRIFFITH L
Citation: J. Gardiner et al., ESTIMATION OF CONFIDENCE-INTERVALS FOR AVERAGE COST-EFFECTIVENESS ANDCOST-EFFECTIVENESS RATIOS FROM SURVIVAL-DATA, Clinical research, 42(2), 1994, pp. 10000224-10000224
Citation: Zy. Li et al., ROLE OF JUNCTIONAL ZONE CELLS BETWEEN PURKINJE-FIBERS AND VENTRICULARMUSCLE IN ARRHYTHMOGENESIS, Cardiovascular Research, 28(8), 1994, pp. 1277-1284
Citation: J. Kupersmith et al., MARKED ACTION-POTENTIAL PROLONGATION AS A SOURCE OF INJURY CURRENT LEADING TO BORDER ZONE ARRHYTHMOGENESIS, The American heart journal, 127(6), 1994, pp. 1543-1553
Authors:
JOSEPH A
TALLEY JD
SHIH A
CRUM T
VOGEL R
KUPERSMITH J
Citation: A. Joseph et al., CLINICAL AND ANGIOGRAPHIC VARIABLES AFFECTING PROGRESSION OF CORONARY-ARTERY DISEASE DETERMINED BY QUANTITATIVE ANGIOGRAPHY, Clinical research, 41(3), 1993, pp. 10000658-10000658
Authors:
GUERRERO P
HOGAN A
GARDINER J
MELLITS D
BAUMGARDNER R
ROVNER D
HOLMESROVNER M
MCLANE A
LEVINE J
GRIFFITH L
KUPERSMITH J
Citation: P. Guerrero et al., RELATIONSHIP OF COST-EFFECTIVENESS OF THE TRANSTHORACIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR TO PATIENT CATEGORY AND CLINICAL STRATEGY, Circulation, 88(4), 1993, pp. 144-144